All the latest quantum computer articles

See the latest stories on quantum computing from eeNews Europe

Friday, March 24, 2017

Medical IoT developer licenses 86 Siemens patents for self-healing networks

By Nick Flaherty

Nexeon MedSystems in the US has licensed a portfolio of IoT patents from Marathon Patent Group. The portfolio of 86 patents originated from Siemens and covers the interconnection via the internet of computing devices embedded in everyday objects, enabling them to send and receive data. The technology can be used in a variety of medical device applications, most notably in hospitals, nursing facilities, or patients' homes.

"The data gathered in these IoT systems can be utilized to help improve the programming for implantable devices," said Nexeon Chairman and CEO Will Rosellini. "An average patient with a chronic disease typically takes more than five different medications everyday, most of which need to be taken at different times of the day and have specific dietary recommendations to accompany the dosages. This same patient is typically demonstrating symptoms associated with cognitive, psychiatric, and motor disorders as well. The promise of keeping the device in the right therapeutic range with data from the IoT is extraordinary."

The portfolio covers self-healing control networks for building automation systems in the hospital and the home. The patents are relevant to wireless mesh networks for use in the IoT and enable simple commissioning, application level security, simplified bridging, and end-to-end IP security.

There is a growing trend in electrophysiology toward remote home-monitoring of implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, and implantable cardiac monitors (ICMs). Nexeon has engaged consultants Battelle to define the data structures and cybersecurity protocols needed to provide the framework for deep learning.

"Siemens is one of the most innovative firms in the world," said Rosellini. "Integrating their network innovation with our patient-specific solutions will substantially reduce the burden of chronic disease. By addressing this unmet need, we will create tremendous value in the form of better, faster care with fewer in-office visits required, easier access to more accurate patient information, and decreased complications and undesired side effects due to more precise therapy and better monitoring."

Related stories: 

No comments: